111 related articles for article (PubMed ID: 187700)
21. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
[TBL] [Abstract][Full Text] [Related]
22. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
24. Immune status of children one to four years of age as determined by history and antibody measurement.
Gold E; Fevrier A; Hatch MH; Herrmann KL; Jones WL; Krugman RD; Parkman PD
N Engl J Med; 1973 Aug; 289(5):231-5. PubMed ID: 4351596
[No Abstract] [Full Text] [Related]
25. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
26. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
27. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
Wolff MH; Marklein G; Schneweis KE; Stifter G
Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
[No Abstract] [Full Text] [Related]
28. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
29. [Peculiarities of immune responses during general anesthesia in otosurgery].
Starchenko AA; Komarets SA; Lavrenova GV; Kraskovskaia-Dimitriuk SV; Prilukova TI
Anesteziol Reanimatol; 2002; (4):46-8. PubMed ID: 12462779
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the immune status against the viruses of measles, mumps, rubella, and hepatitis B in a cohort of students from the province of Como].
Fraizzoli G; Sesana BM
Ann Ig; 1989; 1(5):1163-71. PubMed ID: 2483899
[TBL] [Abstract][Full Text] [Related]
31. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
Kodama S; Hirano T; Abe N; Suzuki M
Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
[TBL] [Abstract][Full Text] [Related]
33. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
Eick AA; Hu Z; Wang Z; Nevin RL
Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
[TBL] [Abstract][Full Text] [Related]
34. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
Narayan KM; Moffat MA
Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
[TBL] [Abstract][Full Text] [Related]
35. Evidence of local antibody response against Alloiococcus otitidis in the middle ear cavity of children with otitis media.
Harimaya A; Takada R; Himi T; Yokota S; Fujii N
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):41-5. PubMed ID: 17094788
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333
[TBL] [Abstract][Full Text] [Related]
38. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus.
Hyöty H; Huupponen T; Leinikki P
Clin Exp Immunol; 1985 Apr; 60(1):139-44. PubMed ID: 4006299
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
[No Abstract] [Full Text] [Related]
40. The use of IgM antibody responses in the diagnosis of primary infections to measles, rubella, mumps, and M. Parainfluenzae viruses.
Bringuier JP; Andre J; Sohier R
Med Microbiol Immunol; 1978; 164(4):299-305. PubMed ID: 45605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
